Skip to main content
. 2022 Aug 6;12:100371. doi: 10.1016/j.ajpc.2022.100371

Table 4.

Factors not included in risk calculators.

Patient A Patient B
Required by calculator
Age 40 40
Gender Male Male
Race Non-African American Non-African American
Smoker No No
Treated for diabetes No No
Treated for Hypertension No No
Total Cholesterol (mg/dl) 175 220
HDL cholesterol (mg/dl) 55 55
Systolic blood pressure (mmHg) 110 110
Diastolic blood pressure (mmHg) 70 70
Not included in calculator Patient A Patient B
Fasting Triglycerides (mg/dl) 80 210
LDL-C (mg/dl) 75 150
LDL-P (Nmol/L) 800 2300
Strong family history of ASCVD No Yes
Hemoglobin A1C (%) 5.4 6.3
Waist circumference (inches) 35 42
Lipoprotein (a) (mg/dl) 70 250
AHA/ACC Risk Score by calculator
(% ten-year risk) 0.6% 0.9%

Consider two hypothetical male non-African-American patients, each 40 years old and their AHA Risk Calculator scores as follows (Patient B has a common profile) (Table 4). The latest guidelines recommend taking ancillary factors into account, as for Patient B, but with a risk score below 1%, most calculator users would be unlikely to recommend treatment for Patient B, yet he appears at very high risk of an acute event in the relatively near future, as well as slow-developing manifestations of atherosclerosis. Changing only the age for Patient B to 60 years in the AHA Risk Calculator means a Risk Score of only 6.8%, still below the treatment threshold of 7.5%.

Every decade of delay in treatment could mean risk of an acute event, damage to other organs, poor aging and ever greater physiological resistance to treatment once finally begun.

Treating Patient B at age 40 or younger would likely prevent premature morbidity and mortality and would be significantly easier, safer and more effective.